Keyphrases
Withanolides
100%
Withaferin A
95%
Heat Shock Protein 90 (Hsp90)
84%
Cisplatin
79%
Hsp90 Inhibitor
78%
Adrenocortical Carcinoma
77%
Antiproliferative Activity
64%
Induced Apoptosis
61%
Melanoma
55%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
54%
Tumor
44%
Primary Hyperparathyroidism (pHPT)
43%
Hyaluronan
43%
Lymphatics
42%
Physalis Longifolia
37%
Heat Shock Protein 90 Inhibitor
37%
Synthetic High-density Lipoprotein
33%
Metastatic Melanoma
33%
Thyroid Cancer
32%
Nanoconjugates
32%
In Cancer
31%
Cytotoxicity
30%
Medullary Thyroid Carcinoma
29%
Parathyroidectomy
28%
Triacetate
27%
Novobiocin
26%
Intralymphatic
26%
Heat Shock Response
26%
Lymphatic System
25%
Nanoparticles
25%
Combination Therapy
24%
Anticancer Activity
23%
Mitogen-activated Protein Kinase
23%
Chemotherapy
22%
Malignancy
21%
Apoptosis
21%
Entrepreneurship
21%
Adrenocortical Carcinoma Cells
20%
Western Blot Analysis
20%
Overall Survival
20%
Parathyroid Hormone Levels
20%
Long Non-coding RNA (LncRNA)
19%
Head-and-neck
19%
Phosphorylation
19%
Terminal Heat
19%
Physalis
18%
Cancer Cell Lines
18%
Client Proteins
18%
Novel Therapeutics
18%
Dose Effect
17%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
97%
Withanolide
93%
Withaferin A
86%
Cisplatin
79%
Adrenal Cortex Carcinoma
67%
Thyroid Cancer
65%
Heat Shock Protein 90 Inhibitor
57%
Head and Neck Squamous Cell Carcinoma
54%
Neoplasm
53%
Breast Cancer
52%
Melanoma
51%
Diseases
50%
Hyaluronic Acid
44%
Chemotherapy
40%
Physalis
39%
Antiproliferative Activity
37%
IC50
37%
Cytotoxicity
34%
High Density Lipoprotein
33%
Western Blot
28%
Structure Activity Relationship
25%
Nanoparticle
25%
Combination Therapy
24%
Squamous Cell Carcinoma
24%
Doxorubicin
22%
Nanocarrier
22%
Thyroid Medullary Carcinoma
21%
Heat Shock Protein 90
21%
Triple Negative Breast Cancer
20%
Carboxamide
19%
Nanoconjugate
19%
Glioblastoma
18%
Clinical Trial
18%
Natural Product
17%
Sorafenib
16%
Novobiocin
16%
Deferoxamine
16%
Mitogen Activated Protein Kinase Kinase Inhibitor
16%
Metastatic Melanoma
16%
Parathyroid Hormone
16%
Neuroblastoma
16%
Lactone
16%
Tanespimycin
16%
Chaperone
16%
Phosphotransferase
14%
Protein Tyrosine Kinase
14%
Differentiated Thyroid Cancer
14%
Cell Viability
14%
Recurrent Disease
13%
Vemurafenib
13%
Medicine and Dentistry
Melanoma
81%
Diseases
53%
Withanolide
44%
Thyroid Cancer
44%
Primary Hyperparathyroidism
43%
Parathyroidectomy
43%
Adrenal Cortex Carcinoma
42%
Parathyroid Hormone
39%
Lymph Duct
38%
In Vitro
38%
Surgeon
34%
Hsp90 Inhibitor
34%
Cancer
34%
Metastatic Carcinoma
32%
Head and Neck Squamous Cell Carcinoma
29%
Carboxy Terminal Sequence
29%
Programmed Cell Death
28%
Withaferin A
28%
Malignant Neoplasm
27%
Restylane
26%
Cisplatin
26%
Neoplasm
25%
Recurrent Disease
25%
Thyroidectomy
24%
Cancer Cell
22%
Metastatic Melanoma
22%
Cancer Stem Cell
21%
Neck
21%
IC50
21%
Thyroid Medullary Carcinoma
21%
Lymphatic System
21%
Positron Emission Tomography
21%
Fine-Needle Aspiration
19%
Isotopes of Calcium
19%
Targeted Therapy
19%
Conjugate
18%
Hormone Determination
18%
Breast Cancer
17%
Sentinel Lymph Node Biopsy
16%
Breast Reconstruction
16%
Parathyroid
16%
Thyroid Nodule
16%
Deferoxamine
16%
Cell Cycle
16%
Overall Survival
15%
Western Blot
15%
General Surgery
15%
Patient Care
15%
Fluorodeoxyglucose
14%
Fluorodeoxyglucose F 18
13%